SRNE

PINK Sorrento Therapeutics, Inc.
Oct 29, 2026 · 1:20 AM ET EOD Market Closed

$0.0007 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0007, and at the day’s high of $0.0007

YTD change
-75.00%
vs 20-day SMA
+25.00%
vs 200-day SMA
-53.64%

Price ranges

Previous day
$0.0001 $0.0002
open $0.0001 close $0.0001
+$0.0000 (+0.00%)
Today
$0.0001 $0.0007
open $0.0001 now $0.0007
+$0.0006 (+550.00%)
Past week
$0.0001 $0.0046
from $0.0008 now $0.0007
-$0.0002 (-18.75%)
Past month
$0.0001 $0.0046
from $0.0008 now $0.0007
-$0.0002 (-18.75%)
This year
$0.0001 $0.0100
from $0.0026 now $0.0007
-$0.0020 (-75.00%)

Price & Performance

-0.00 (-12.50%) / 6M

$0.0000$0.0005$0.0011$0.0016Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.3% away from all-time highs of $0.0985
  • SRNE is down 75% since the beginning of the year
  • SRNE is down 91% over the past 12 months
  • SRNE is down 19% over the past 1 month
  • 1% of all SRNE investors are betting against SRNE

SRNE reads not so good: price sits above one of the two key moving averages, the 12-month move is -90.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta -4.27

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $358.3K

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,288.30 +0.50%
JNJ Johnson & Johnson $271.04 +0.86%
ABBV AbbVie, Inc. $285.99 -0.14%
MRK Merck & Co., Inc. $140.93 -0.63%
RHHVF Roche Holding Ltd $487.52 +1.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.